Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Atieh Yaghoubi, Saeid Amel Jamehdar, Aref Movaqar, Nasrin Milani & Saman Soleimanpour. (2021) An effective drug against COVID-19: reality or dream?. Expert Review of Respiratory Medicine 15:4, pages 505-518.
Read now
Read now
Jaffar A. Al-Tawfiq & Kareem Hinedi. (2018) The calm before the storm: clinical observations of Middle East respiratory syndrome (MERS) patients. Journal of Chemotherapy 30:3, pages 179-182.
Read now
Read now
Ali A. Rabaan. (2017) Middle East respiratory syndrome coronavirus: five years later. Expert Review of Respiratory Medicine 11:11, pages 901-912.
Read now
Read now
Articles from other publishers (33)
Amany Y. El-Sayed, Mahmoud Shehata, Sara H. Mahmoud, Mahmoud ElHefnawi, Dina M. Seoudi & Mohamed A. Ali. (2023) Evaluation of Predicted siRNA as an Antiviral against MERS-CoV Targeting the Membrane Gene in the Vero Cell Line. Microbiology Research 14:4, pages 1687-1701.
Crossref
Crossref
Arkajit De, Somdatta Bhattacharya, Bishal Debroy, Arijit Bhattacharya & Kuntal Pal. (2023) Exploring the pharmacological aspects of natural phytochemicals against SARS-CoV-2 Nsp14 through an in silico approach. In Silico Pharmacology 11:1.
Crossref
Crossref
Gandarvakottai Senthilkumar Arumugam, Kannan Damodharan, Mukesh Doble & Sathiah Thennarasu. (2022) Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity. Molecular Biomedicine 3:1.
Crossref
Crossref
Alisa Nasibullina, Milyausha Kabirova, Il'dar Kabirov & Damir Valishin. (2022) DENTAL QUALITY OF LIFE SCORE OHIP-49-RU IN PATIENTS WITH LABORATORY-CONFIRMED SARS-COV-2 DIAGNOSIS. Actual problems in dentistry 18:2, pages 68-73.
Crossref
Crossref
Gaber El-Saber Batiha, Ali I. Al-Gareeb, Hebatallah M. Saad & Hayder M. Al-kuraishy. (2022) COVID-19 and corticosteroids: a narrative review. Inflammopharmacology 30:4, pages 1189-1205.
Crossref
Crossref
Adrián Sánchez-Montalvá, Júlia Sellarés-Nadal, Juan Espinosa-Pereiro, Nuria Fernández-Hidalgo, Santiago Pérez-Hoyos, Fernando Salvador, Xavier Durà, Marta Miarons, Andrés Antón, Simeón Eremiev-Eremiev, Abiu Sempere-González, Arnau Monforte-Pallarés, Pau Bosch-Nicolau, Salvador Augustin, Júlia Sampol, Alfredo Guillén-del-Castillo & Benito Almirante. (2022) Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab. Medicina Clínica 158:11, pages 509-518.
Crossref
Crossref
Adrián Sánchez-Montalvá, Júlia Sellarés-Nadal, Juan Espinosa-Pereiro, Nuria Fernández-Hidalgo, Santiago Pérez-Hoyos, Fernando Salvador, Xavier Durà, Marta Miarons, Andrés Antón, Simeón Eremiev-Eremiev, Abiu Sempere-González, Arnau Monforte-Pallarés, Pau Bosch-Nicolau, Salvador Augustin, Júlia Sampol, Alfredo Guillén-del-Castillo & Benito Almirante. (2022) Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab. Medicina Clínica (English Edition) 158:11, pages 509-518.
Crossref
Crossref
Michael D. Scholle, Cheng Liu, Jerome Deval & Zachary A. Gurard-Levin. (2021) Label-Free Screening of SARS-CoV-2 NSP14 Exonuclease Activity Using SAMDI Mass Spectrometry. SLAS Discovery 26:6, pages 766-774.
Crossref
Crossref
James Ropa, Thao Trinh, Arafat Aljoufi & Hal E. Broxmeyer. (2021) Consequences of coronavirus infections for primitive and mature hematopoietic cells: new insights and why it matters. Current Opinion in Hematology 28:4, pages 231-242.
Crossref
Crossref
Claudio N. Cavasotto, Maximiliano Sánchez Lamas & Julián Maggini. (2021) Functional and druggability analysis of the SARS-CoV-2 proteome. European Journal of Pharmacology 890, pages 173705.
Crossref
Crossref
Guilherme Antonio de Souza Silva, Suéllen Pedrosa da Silva, Marcos Aurélio Santos da Costa, Abdênego Rodrigues da Silva, Robson Raion de Vasconcelos Alves, Fernanda das Chagas Ângelo Mendes Tenório, Alanne Rayssa da Silva Melo, Antonio Carlos de Freitas & Cristiane Moutinho Lagos de Melo. (2020) SARS-CoV, MERS-CoV and SARS-CoV-2 infections in pregnancy and fetal development. Journal of Gynecology Obstetrics and Human Reproduction 49:10, pages 101846.
Crossref
Crossref
Rupinder Mann, Abhilash Perisetti, Mahesh Gajendran, Zainab Gandhi, Chandraprakash Umapathy & Hemant Goyal. (2020) Clinical Characteristics, Diagnosis, and Treatment of Major Coronavirus Outbreaks. Frontiers in Medicine 7.
Crossref
Crossref
Lucie Sauerhering, Alexandra Kupke, Lars Meier, Erik Dietzel, Judith Hoppe, Achim D. Gruber, Stefan Gattenloehner, Biruta Witte, Ludger Fink, Nina Hofmann, Tobias Zimmermann, Alexander Goesmann, Andrea Nist, Thorsten Stiewe, Stephan Becker, Susanne Herold & Christin Peteranderl. (2020)
Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus
via
interferon-λ
in vitro
and in mice
. European Respiratory Journal 56:5, pages 1901826.
Crossref
Crossref
Michele Protti, Roberto Mandrioli & Laura Mercolini. (2020) Quantitative microsampling for bioanalytical applications related to the SARS-CoV-2 pandemic: Usefulness, benefits and pitfalls. Journal of Pharmaceutical and Biomedical Analysis 191, pages 113597.
Crossref
Crossref
Kaan Kucukoglu, Nagihan Faydalı & Dilek Bul. (2020) What are the drugs having potential against COVID-19?. Medicinal Chemistry Research 29:11, pages 1935-1955.
Crossref
Crossref
Keitty Regina Cordeiro de Andrade, Viviane Karoline da Silva Carvalho, Cecília Menezes Farinasso, Aurelina Aguiar de Lima, Roberta Borges Silva, Virginia Kagure Wachira, Helaine Carneiro Capucho, Patricia Medeiros de Souza, Tazio Vanni, Camile Giaretta Sachetti & Daniela Fortunato Rêgo. (2020) Terapia medicamentosa para infecções por coronavírus em humanos: revisão sistemática rápida. Ciência & Saúde Coletiva 25:9, pages 3517-3554.
Crossref
Crossref
Nosheen Masood, Saima Shakil Malik, Muhammad Naqqi Raja, Sumaira Mubarik & Chuanhua Yu. (2020) Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2). Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Linzi Fan, Shuang Jiang, Xinrong Yang, Zhibin Wang & Chunjuan Yang. (2020) COVID-19 Drug Treatment in China. Current Pharmacology Reports 6:4, pages 146-154.
Crossref
Crossref
Francisca Verdugo-Paiva, Ariel Izcovich, Martín Ragusa & Gabriel Rada. (2020) Lopinavir/ritonavir for COVID-19: A living systematic review. Medwave 20:06, pages e7966-e7966.
Crossref
Crossref
Suranga L Senanayake. (2020) Overcoming nonstructural protein 15-nidoviral uridylate-specific endoribonuclease (nsp15/NendoU) activity of SARS-CoV-2. Future Drug Discovery 2:3.
Crossref
Crossref
Yang Yu, Qianling Shi, Peng Zheng, Lei Gao, Haiyuan Li, Pengxian Tao, Baohong Gu, Dengfeng Wang & Hao Chen. (2020) Assessment of the quality of systematic reviews on COVID‐19: A comparative study of previous coronavirus outbreaks. Journal of Medical Virology 92:7, pages 883-890.
Crossref
Crossref
Oleg Zhirnov. (2020) Coronavirus infection: principles of ethyotropic chemotherapy. Novejshie zarubezhnye i otechestvennye lekarstvennye preparaty: farmakoterapija, farmakodinamika, farmakokinetika (Newest Foreign and Domestic Preparations: Pharmacotherapy, Pharmacodynamics, Pharmacokinetics):3, pages 18-39.
Crossref
Crossref
O. P. Zhirnov. (2020) Molecular Targets in the Chemotherapy of Coronavirus Infection. Biochemistry (Moscow) 85:5, pages 523-530.
Crossref
Crossref
Sandro G. Viveiros Rosa & Wilson C. Santos. (2020) Clinical trials on drug repositioning for COVID-19 treatment. Revista Panamericana de Salud Pública 44, pages 1.
Crossref
Crossref
David A. Schwartz & Ashley L. Graham. (2020) Potential Maternal and Infant Outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections. Viruses 12:2, pages 194.
Crossref
Crossref
Azadeh Laali, Alireza Tabibzadeh, Maryam Esghaei, Parastoo Yousefi, Saber Soltani, Hossein Ajdarkosh, Alireza Mosavi-Jarrahi & MohamadHadi Karbalaie Niya. (2020) Liver function tests profile in COVID-19 patients at the admission time: A systematic review of literature and conducted researches. Advanced Biomedical Research 9:1, pages 74.
Crossref
Crossref
Hisham Momattin, Anfal Y. Al-Ali & Jaffar A. Al-Tawfiq. (2019) A Systematic Review of therapeutic agents for the treatment of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Travel Medicine and Infectious Disease 30, pages 9-18.
Crossref
Crossref
Mohammad Amin Behzadi & Victor H. Leyva-Grado. (2019) Overview of Current Therapeutics and Novel Candidates Against Influenza, Respiratory Syncytial Virus, and Middle East Respiratory Syndrome Coronavirus Infections. Frontiers in Microbiology 10.
Crossref
Crossref
Hyun Lee, Jinhong Ren, Russell P. Pesavento, Isabel Ojeda, Amy J. Rice, Haining Lv, Youngjin Kwon & Michael E. Johnson. (2019) Identification and design of novel small molecule inhibitors against MERS-CoV papain-like protease via high-throughput screening and molecular modeling. Bioorganic & Medicinal Chemistry 27:10, pages 1981-1989.
Crossref
Crossref
Sarah H. Alfaraj, Jaffar A. Al-Tawfiq, Talal A. Altuwaijri & Ziad A. Memish. (2018) Middle East respiratory syndrome coronavirus in pediatrics: a report of seven cases from Saudi Arabia. Frontiers of Medicine 13:1, pages 126-130.
Crossref
Crossref
H.S. Li, Denise I.T. Kuok, M.C. Cheung, Mandy M.T. Ng, K.C. Ng, Kenrie P.Y. Hui, J.S.Malik Peiris, Michael C.W. Chan & John M. Nicholls. (2018) Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model. Antiviral Research 155, pages 89-96.
Crossref
Crossref
François FerronLorenzo SubissiAna Theresa Silveira De MoraisNhung Thi Tuyet LeMarion SevajolLaure GluaisEtienne DecrolyClemens Vonrhein, Gérard Bricogne, Bruno CanardIsabelle Imbert. (2017) Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA. Proceedings of the National Academy of Sciences 115:2.
Crossref
Crossref
Ali A. Rabaan, Shamsah H. Alahmed, Ali M. Bazzi & Hatem M. Alhani. (2017) A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective. Journal of Medical Microbiology 66:9, pages 1261-1274.
Crossref
Crossref